血栓式抗PF4免疫疾病:HIT,VITT,以及其他疾病
Andreas Greinacher1, Theodore E Warkentin2
1Institut für Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
对血小板因子4 (PF4) 的抗体会导致血栓形成. 新的研究将它们分类为1型 (非致病性),2型 (依赖氨酸) 和3型 (依赖氨酸),指导治疗严重病例,如疫苗诱导的免疫血栓性血栓细胞缩 (VITT).
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 抗血小板因子4 (PF4) 的抗体可能会导致严重的前血栓性疾病与血栓缩.
- 肝素诱导的血小板缺血 (HIT) 是一种原型性疾病,由通过FcγIIa受体的血小板激活介导.
- 疫苗诱发的免疫血栓性血栓性缺血症 (VITT) 是一种罕见的,主要是素独立的抗PF4抗体疾病.
研究的目的:
- 根据它们的致病机制区分和分类抗PF4抗体.
- 通知HIT和VITT的管理,特别是严重或不典型的表现.
- 为抗PF4抗体提出一种新的分类系统.
主要方法:
- 对PF4的抗体结合表位的分析.
- 开发免疫测试以区分HIT类和VITT类抗体.
- 抗体类型与血栓事件和治疗反应的临床相关性.
主要成果:
- 抗PF4抗体分为1型 (非致病性),2型 (依赖氨酸) 和3型 (依赖氨酸).
- 与VITT和自身免疫性HIT相关的3型抗体需要抗凝剂加上静脉注射免疫球蛋白 (IVIG).
- 区分HIT和VITT抗体对于适当的治疗策略至关重要.
结论:
- 抗PF4抗体的新分类 (类型1,2,3) 澄清了病原性机制.
- 3型抗体需要抗凝血和辅助治疗,如IVIG,用于严重的高凝血.
- 这一框架有助于理解和管理与抗PF4抗体相关的复杂血栓性疾病.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708
01:24Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
526
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
01:22Formation of the Platelet Plug
6.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.4K
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K